Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00607867 · ClinicalTrials.gov registry record · NA
LoBAG30 Diet in Patients on Metformin
A NA study, sponsored by US Department of Veterans Affairs.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00607867: Clinical Trial NA study, sponsored by US Department of Veterans Affairs.
NCT00607867 is a NA study that was terminated before completion, run by US Department of Veterans Affairs. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00607867, a NA study, was terminated before completion, sponsored by US Department of Veterans Affairs.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
We will determine the metabolic response to a Low Biologically Available Glucose Diet (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in whom the glycohemoglobin is not at an acceptable level (\>8.0%). Our hypothesis is that introduction of a LoBAG30 diet to subjects currently treated with a full therapeutic dose of metformin will improve blood glucose control in people who have not achieved an acceptable total glycohemoglobin on metformin alone.
Primary Outcome
Hemoglobin A1c measured before and after 5 weeks on the diet
Interventions
- OTHER Control Diet
- OTHER LoBAG30 diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
| Phase | NA |
Why NCT00607867 stopped before completion
NCT00607867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Diet is the first listed.
NCT00607867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00607867 about?
NCT00607867 is a clinical study titled "LoBAG30 Diet in Patients on Metformin". We will determine the metabolic response to a Low Biologically Available Glucose Diet (LoBAG30) in subjects currently receiving the maximum dose of metformin as monotherapy in whom the glycohemoglobin is not at an acceptable level (\>8.0%). Our hypothesis is that introduction of a LoBAG30 diet to su...
What is the current status of trial NCT00607867?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2008-04. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00607867?
The interventions under investigation include: Control Diet (OTHER), LoBAG30 diet (OTHER).
Who is sponsoring clinical trial NCT00607867?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00607867's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia